Miqin Zhang - Bothell WA, US Richard G. Ellenbogen - Seattle WA, US Raymond W. Sze - Mclean VA, US Omid Veiseh - Kirkland WA, US James M. Olson - Seattle WA, US Mandana Veiseh - Emeryville CA, US Patrick Gabikian - Seattle WA, US
Assignee:
Washington, University of - Seattle WA Fred Hutchinson Cancer Research Center - Seattle WA
International Classification:
A61K 49/00
US Classification:
424 96
Abstract:
A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.
Miqin Zhang - Bothell WA, US Conroy Sun - Kirkland WA, US Omid Veiseh - Kirkland WA, US Narayan Bhattarai - Seattle WA, US
Assignee:
Washington, University of - Seattle WA
International Classification:
A61K 49/18 A61K 49/00 A61K 9/16 G01N 33/567
US Classification:
424 9322, 424 91, 424 93, 424493, 435 721
Abstract:
Nanoparticle having a chitosan-polyethylene oxide oligomer copolymer coating, and methods for making and using the nanoparticle are provided. The nanoparticle can have a core that includes a material that imparts magnetic resonance imaging activity to the particle and, optionally, one or more of an associated targeting agent, fluorescent agent, or therapeutic agent.
Polyarginine-Coated Magnetic Nanovector And Methods Of Use Thereof
Polyarginine-coated nanoparticle, and methods for making and using the nanoparticle. The nanoparticle can have a core that includes a material that imparts magnetic resonance imaging activity to the particle and, optionally, include one or more of an associated therapeutic agent, targeting agent, and diagnostic agent.
Chlorotoxin-Labeled Nanoparticle Compositions And Methods For Targeting Primary Brain Tumors
Miqin Zhang - Bothell WA, US James Olson - Seattle WA, US Raymond Sze - Mercer Island WA, US Richard Ellenbogen - Seattle WA, US Omid Veiseh - Kirkland WA, US Conroy Sun - Kirkland WA, US Jonathan Gunn - Seattle WA, US
International Classification:
G01N 33/574
US Classification:
435007230, 435455000, 977902000
Abstract:
Chlorotoxin-labeled nanoparticles that target primary brain tumors, compositions that include the nanoparticles, methods of imaging tissues using the nanoparticles, and methods for treating tissues using the nanoparticles.
Compositions, Devices, And Methods For Treating Fabry Disease
- Cambridge MA, US Michael Beauregard - Boston MA, US Guillaume Carmona - Cambridge MA, US Francisco Caballero Gonzalez - Brookline MA, US Richard Heidebrecht - Somerville MA, US Erika Ellen Johnston - Cambridge MA, US Robert James Miller - East Bridgewater MA, US Owen O'Connor - Raynham MA, US Matthias Alexander Oberli - Cambridge MA, US David Peritt - Skokie IL, US Jared A. Sewell - Somerville MA, US Devyn McKinley Smith - Barrington RI, US Omid Veiseh - Bellaire TX, US Jeffrey Charles Way - Cambridge MA, US Paul Kevin Wotton - Boston MA, US Zoe Yin - Boston MA, US Elina Makino - Winchester MA, US Brian Richard Fluharty - Boston MA, US Marianthi Papakosta - Cambridge MA, US
Described herein are RPE cells engineered to secrete a GLA protein, as well as compositions, pharmaceutical preparations, and implantable devices comprising the engineered RPE cells, and methods of making and using the same for treating Fabry disease.
High Throughput Genetic Barcoding And Analysis Methods
- Houston TX, US Ping SONG - Houston TX, US Omid VEISEH - Houston TX, US Siavash PARKHIDEH - Houston TX, US Sudip MUKHERJEE - Houston TX, US Maria Isabel RUOCCO - Houston TX, US Boram KIM - Houston TX, US Yuxuan CHENG - Houston TX, US
Provided herein are high-throughput methods for genetic barcoding and analysis, e.g., for tagging each biomaterial apsule with a barcode cell. These barcode cells are derived from patient samples, and thus embody natural human genetic variation. Also provided are SNP panels that can be used as genetic barcodes to identify the identity of a cell.
- Cambridge MA, US Michael Beauregard - Boston MA, US Guillaume Carmona - Cambridge MA, US Francisco Caballero Gonzalez - Brookline MA, US Richard Heidebrecht - Somerville MA, US Erika Ellen Johnston - Cambridge MA, US Robert James Miller - East Bridgewater MA, US Matthias Alexander Oberli - Cambridge MA, US Owen O'Connor - Raynham MA, US David Peritt - Skokie IL, US Jared A. Sewell - Somerville MA, US Devyn McKinley Smith - Barrington RI, US Omid Veiseh - Bellaire TX, US Paul Kevin Wotton - Boston MA, US
Described herein are particles comprising a first compartment, a second compartment, and a compound of Formula (I), as well as compositions and methods of making and using the same. The particles may comprise a cell capable of expressing a therapeutic agent useful for the treatment of a disease, disorder, or condition described herein.
Methods, Compositions, And Implantable Elements Comprising Stem Cells
- Cambridge MA, US David Peritt - Skokie IL, US Omid Veiseh - Bellaire TX, US Richard Heidebrecht - Somerville MA, US Robert James Miller - East Bridgewater MA, US
Described herein are cell compositions comprising a mesenchymal stem function cell (MSFC), e.g., an engineered MSFC or derivatives thereof, as well as compositions, pharmaceutical products, and implantable elements comprising an MSFC, and methods of making and using the same. The cells and compositions may express a therapeutic agent useful for the treatment of a disease, disorder, or condition described herein.
Sigilon Therapeutics, Inc. Feb 2016 - Sep 2017
Founding Scientist and Head of Innovation
Rice University Feb 2016 - Sep 2017
Assistant Professor and Cprit Scholar In Cancer Research Department of Bioengineering
Boston Children's Hospital Nov 2011 - May 2016
Research Fellow
Massachusetts Institute of Technology (Mit) Nov 2011 - May 2016
Postdoctoral Research Fellow
Sigilon Therapeutics, Inc. Nov 2011 - May 2016
Co-Founder
Education:
Massachusetts Institute of Technology 2011 - 2016
University of Washington 2005 - 2009
Doctorates, Doctor of Philosophy, Engineering, Materials Science, Nanotechnology
Western Washington University 1997 - 2002
Bachelors, Bachelor of Science, Biology
Skills:
Biomaterials Nanotechnology Nanoparticles Cell Drug Delivery Cell Culture Tissue Engineering Cancer Fluorescence Microscopy Nanomaterials Microscopy Molecular Biology Cell Biology Materials Science Biochemistry Biosensors Flow Cytometry Fluorescence Western Blotting Protein Purification Scanning Electron Microscopy Elisa Immunohistochemistry Tissue Culture Protein Expression Cancer Research Electron Microscopy Immunology Stem Cells Protein Chemistry Molecular Cloning Sirna Polymers Bioconjugate Chemistry Fluorescence Spectroscopy Assay Development In Vivo In Vitro Gene Therapy Molecular Imaging Bioengineering Animal Models Transfection Microfluidics Diabetes Mri Brain Tumors Fibrosis Biophysics
Interests:
Science and Technology Education Health
Languages:
English Persian
Youtube
Bioengineers at Rice tackle ovarian and color...
Rice University Bioengineer Omid Veiseh and colleagues created tiny im...
Duration:
3m 52s
Study shows how breast implants affect immune...
A new study, co-authored by a Rice University professor, looks at how ...
Duration:
4m 39s
Drug Factory Implants in Ovarian Cancer: Lear...
Speaker: Dr. Omid Veiseh, Professor, Rice University.
Duration:
10m 14s
OTT Technology Spotlight Season 1 Episode 3: ...
The Veiseh laboratory utilizes advanced nano, micro, and macro fabrica...
Duration:
2m
Drug Factory Implants Successfully Cure Certa...
Here's a pic of Rice University bioengineer Omid Veiseh with a vial of...
Duration:
6m 43s
Sushi Implant - 2013 Image Award Winner
Omid Veiseh, Joshua Doloff, Minglin Ma, Alan Chiu, and Arturo Vegas ex...
Duration:
3m 55s
Masters of Disguise: 2015 Image Award winner
Andrew Bader, Omid Veiseh, and Arturo Vegas share the story of stealth...
Duration:
3m 20s
Innovation in Medicine to address COVID-19
"Innovation in Medicine to address COVID-19 by Dr. Omid Veiseh, Ph.D.
Duration:
34m 3s
Googleplus
Omid Veiseh
Work:
Massachusetts Institute of Technology - Postdoctoral Research Fellow (2011)
News
Feds fund $45M Rice-led research that could slash US cancer deaths by 50%
Instead of tethering patients to hospital beds, IV bags and external monitors, well use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time, said Rice bioengineer Omid Veiseh, principal investigator (Pedu/news/files/2023/09/0925_THOR-ajov222bm-lg2k.jpg CAPTION: Omid Veiseh (right) and Amir Jazaeri in Veisehs Rice University laboratory in August 2023. Veiseh is principal investigator on the targeted hybrid oncotherapeutic regulation (THOR) project, a $45 million program that the Advanced Rese
Date: Sep 26, 2023
Category: Health
Source: Google
Local scientists worry about NIH's proposed cap on funding for individual labs
The sentiment makes a lot of sense, said Omid Veiseh, a former postdoctoral researcher in the Langer Lab who was recently hired as an assistant professor in the bioengineering department at Rice University in Houston, where he hopes to set up a lab. Junior faculty members, the people starting lab
Date: Jun 07, 2017
Category: Health
Source: Google
Encapsulated pancreatic cells offer new diabetes treatment
"The exciting part of this was being able to show, in an immune-competent mouse, that when encapsulated these cells do survive for a long period of time, at least six months," noted Omid Veiseh, a senior post-doc at the Koch Institute and Boston Children's hospital.
Date: Jan 26, 2016
Category: Health
Source: Google
No more insulin injections? Encapsulated pancreatic cells offer possible new diabetes treatment
"The really exciting part of this was being able to show, in an immune-competent mouse, that when encapsulated these cells do survive for a long period of time, at least six months," says Omid Veiseh, a senior postdoc at the Koch Institute and Boston Children's hospital and co-first author of the Na